Melatonin as an oncostatic agent: Review of the modulation of tumor microenvironment and overcoming multidrug resistance.

[1]  Min Wu,et al.  Role of chemokine systems in cancer and inflammatory diseases , 2022, MedComm.

[2]  Ahsen U. Ahmed,et al.  Hormonal and Genetic Regulatory Events in Breast Cancer and Its Therapeutics: Importance of the Steroidogenic Acute Regulatory Protein , 2022, Biomedicines.

[3]  J. Chia,et al.  The potential role of protease systems in hemophilic arthropathy , 2022, Blood advances.

[4]  Zhulong Chan,et al.  Melatonin Antagonizes Cytokinin Responses to Stimulate Root Growth in Arabidopsis , 2022, Journal of Plant Growth Regulation.

[5]  Sarah M. Heissler,et al.  MARK2 regulates directed cell migration through modulation of myosin II contractility and focal adhesion organization , 2022, Current Biology.

[6]  Yan Peng,et al.  PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway? , 2022, Frontiers in Oncology.

[7]  R. Reiter,et al.  Combination of melatonin with paclitaxel reduces the TLR4-mediated inflammatory pathway, PD-L1 levels, and survival of ovarian carcinoma cells , 2022, Melatonin Research.

[8]  L. Gollahon,et al.  The Complex Biology of the Obesity-Induced, Metastasis-Promoting Tumor Microenvironment in Breast Cancer , 2022, International journal of molecular sciences.

[9]  W. Tan,et al.  High glucose mediates apoptosis and osteogenesis of MSCs via downregulation of AKT-Sirt1-TWIST , 2022, Molecular Biology Reports.

[10]  G. Tanriover,et al.  Effects of melatonin and doxorubicin on primary tumor and metastasis in breast cancer model , 2021, Anti-Cancer Agents in Medicinal Chemistry.

[11]  M. Koh,et al.  Revisiting the HIF switch in the tumor and its immune microenvironment. , 2021, Trends in cancer.

[12]  B. Salhia,et al.  Cancer-Associated Fibroblast Subpopulations With Diverse and Dynamic Roles in the Tumor Microenvironment , 2021, Molecular Cancer Research.

[13]  Chen Liang,et al.  Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives , 2021, Molecular Cancer.

[14]  R. Reiter,et al.  Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved , 2021, International journal of molecular sciences.

[15]  Huabin Zhu,et al.  Melatonin improves the maturation and developmental ability of bovine oocytes by up-regulating GJA4 to enhance gap junction intercellular communication. , 2021, Reproduction, fertility, and development.

[16]  Shuixing Zhang,et al.  Tumor-Associated Macrophages and Their Functional Transformation in the Hypoxic Tumor Microenvironment , 2021, Frontiers in Immunology.

[17]  Sherine F. Elsawa,et al.  Macrophage Polarization States in the Tumor Microenvironment , 2021, International journal of molecular sciences.

[18]  R. Reiter,et al.  Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review , 2021, Antioxidants.

[19]  R. Reiter,et al.  Therapeutic targets of cancer drugs: Modulation by melatonin. , 2020, Life sciences.

[20]  M. Osanai,et al.  Role of tight junctions in the epithelial-to-mesenchymal transition of cancer cells. , 2020, Biochimica et biophysica acta. Biomembranes.

[21]  Ranran Tang,et al.  Melatonin synergizes BRAF‐targeting agent dabrafenib for the treatment of anaplastic thyroid cancer by inhibiting AKT/hTERT signalling , 2020, Journal of cellular and molecular medicine.

[22]  Xuan Peng,et al.  Targeting tumor-associated macrophages in the tumor microenvironment , 2020, Oncology letters.

[23]  Y. Kim,et al.  Inhibition of PI3K/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail/GSK-3/beta-catenin pathway , 2020, Clinical and molecular hepatology.

[24]  T. Efferth,et al.  Medicinal plants and phytochemicals against multidrug-resistant tumor cells expressing ABCB1, ABCG2, or ABCB5: a synopsis of 2 decades , 2020, Phytochemistry Reviews.

[25]  Li-Na Zhang,et al.  Roles of cell fusion between mesenchymal stromal/stem cells and malignant cells in tumor growth and metastasis , 2020, The FEBS journal.

[26]  M. Rashidi,et al.  Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells. , 2020, European journal of pharmacology.

[27]  T. Efferth,et al.  Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance. , 2020, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[28]  Tianyuan Zhang,et al.  [Progress on utilizing mesenchymal stem cells as cellular delivery system for targeting delivery of as drug/gene for anti-tumor therapy]. , 2020, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences.

[29]  R. Reiter,et al.  Melatonin: An atypical hormone with major functions in the regulation of angiogenesis , 2020, IUBMB life.

[30]  Xiuxiu Wang,et al.  Experimental study of the vascular normalization window for tumors treated with apatinib and the efficacy of sequential chemotherapy with apatinib in lung cancer‐bearing mice and patients , 2020, Cancer medicine.

[31]  M. Moloudizargari,et al.  Immunoregulatory role of melatonin in cancer , 2020, Journal of cellular physiology.

[32]  Mu-Kuan Chen,et al.  Effects of miR-34b/miR-892a Upregulation and Inhibition of ABCB1/ABCB4 on Melatonin-Induced Apoptosis in VCR-Resistant Oral Cancer Cells , 2020, Molecular therapy. Nucleic acids.

[33]  Ansar Karimian,et al.  Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons , 2020, IUBMB life.

[34]  J. Mayo,et al.  Melatonin-Induced Cytoskeleton Reorganization Leads to Inhibition of Melanoma Cancer Cell Proliferation , 2020, International journal of molecular sciences.

[35]  N. Takebe,et al.  Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update , 2019, Nature Reviews Clinical Oncology.

[36]  Wamidh H. Talib.  A ketogenic diet combined with melatonin overcomes cisplatin and vincristine drug resistance in breast carcinoma syngraft. , 2019, Nutrition.

[37]  R. Reiter,et al.  Role of melatonin in controlling angiogenesis under physiological and pathological conditions , 2019, Angiogenesis.

[38]  A. Bishayee,et al.  Polyphenols: Major regulators of key components of DNA damage response in cancer. , 2019, DNA repair.

[39]  S. Hill,et al.  Epigenetic inhibition of the tumor suppressor ARHI by light at night‐induced circadian melatonin disruption mediates STAT3‐driven paclitaxel resistance in breast cancer , 2019, Journal of pineal research.

[40]  K. Patel,et al.  Melatonin and its ubiquitous anticancer effects , 2019, Molecular and Cellular Biochemistry.

[41]  Juhee Jeong,et al.  Context Drives Diversification of Monocytes and Neutrophils in Orchestrating the Tumor Microenvironment , 2019, Front. Immunol..

[42]  Huirong Shi,et al.  Exosomes promote pre-metastatic niche formation in ovarian cancer , 2019, Molecular Cancer.

[43]  L. Ferreira,et al.  Melatonin down-regulates microRNA-10a and decreases invasion and migration of triple-negative breast cancer cells , 2019, Melatonin Research.

[44]  M. Clarke.  Clinical and Therapeutic Implications of Cancer Stem Cells. , 2019, The New England journal of medicine.

[45]  H. Parsian,et al.  Crosstalk between Phosphoinositide 3‐kinase/Akt signaling pathway with DNA damage response and oxidative stress in cancer , 2019, Journal of cellular biochemistry.

[46]  Fenghua Chen,et al.  miR-21 regulates growth and EMT in lung cancer cells via PTEN/Akt/GSK3β signaling. , 2019, Frontiers in bioscience.

[47]  Amanda R. Campbell,et al.  Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro , 2019, Journal of Immunotherapy for Cancer.

[48]  J. Edwards,et al.  The NF-KB pathway and endocrine therapy resistance in breast cancer , 2019, Endocrine-related cancer.

[49]  K. Beningo,et al.  Integrins, CAFs and Mechanical Forces in the Progression of Cancer , 2019, Cancers.

[50]  D. Sprinzak,et al.  Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer , 2019, Front. Immunol..

[51]  T. Andl,et al.  Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment , 2019, Front. Cell Dev. Biol..

[52]  D. Noonan,et al.  Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression , 2019, Front. Immunol..

[53]  Johannes A Eble,et al.  The extracellular matrix in tumor progression and metastasis , 2019, Clinical & Experimental Metastasis.

[54]  Serge Haan,et al.  In search of definitions: Cancer‐associated fibroblasts and their markers , 2019, International journal of cancer.

[55]  Shuangyin Han,et al.  Dual role of twist1 in cancer‐associated fibroblasts and tumor cells promoted epithelial‐mesenchymal transition of esophageal cancer , 2019, Experimental cell research.

[56]  W. Guo,et al.  Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits , 2019, Journal of experimental & clinical cancer research : CR.

[57]  Danijela Matic Vignjevic,et al.  Cancer associated fibroblasts: is the force the path to the dark side? , 2019, Current opinion in cell biology.

[58]  Y. Sakai,et al.  The Role of Tumor-Associated Neutrophils in Colorectal Cancer , 2019, International journal of molecular sciences.

[59]  C. Vanhove,et al.  A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy , 2019, Drug delivery.

[60]  A. Hacışevki,et al.  An Overview of Melatonin as an Antioxidant Molecule: A Biochemical Approach , 2018, Melatonin - Molecular Biology, Clinical and Pharmaceutical Approaches.

[61]  Jingwei Shao,et al.  CXCR7 is not obligatory for CXCL12‐CXCR4‐induced epithelial‐mesenchymal transition in human ovarian cancer , 2018, Molecular carcinogenesis.

[62]  M. Yousefi,et al.  Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance , 2018, Journal of cellular physiology.

[63]  T. D. de Gruijl,et al.  Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression , 2018, Front. Immunol..

[64]  L. Ferreira,et al.  Melatonin restrains angiogenic factors in triple‐negative breast cancer by targeting miR‐152‐3p: In vivo and in vitro studies , 2018, Life sciences.

[65]  J. H. Lee,et al.  Melatonin and 5‐fluorouracil co‐suppress colon cancer stem cells by regulating cellular prion protein‐Oct4 axis , 2018, Journal of pineal research.

[66]  S. Arias-Santiago,et al.  Epithelial In vitro Differentiation of Mesenchymal Stem Cells. , 2018, Current stem cell research & therapy.

[67]  J. H. Lee,et al.  Melatonin Promotes Apoptosis of Colorectal Cancer Cells via Superoxide-mediated ER Stress by Inhibiting Cellular Prion Protein Expression , 2018, AntiCancer Research.

[68]  Y. Hida,et al.  Contribution of Tumor Endothelial Cells in Cancer Progression , 2018, International journal of molecular sciences.

[69]  Giuseppe Curigliano,et al.  Targeting the microenvironment in solid tumors. , 2018, Cancer treatment reviews.

[70]  J. H. Lee,et al.  Melatonin Promotes Apoptosis of Oxaliplatin-resistant Colorectal Cancer Cells Through Inhibition of Cellular Prion Protein. , 2018, Anticancer research.

[71]  M. Cano,et al.  Role of Melatonin in the Inflammatory Process and its Therapeutic Potential. , 2018, Current pharmaceutical design.

[72]  Dhiraj Kumar,et al.  Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges , 2018, Molecular Cancer.

[73]  A. Ridley,et al.  Rho GTPase signaling complexes in cell migration and invasion , 2018, The Journal of cell biology.

[74]  I. Bejarano,et al.  Participation of MT3 melatonin receptors in the synergistic effect of melatonin on cytotoxic and apoptotic actions evoked by chemotherapeutics , 2017, Cancer Chemotherapy and Pharmacology.

[75]  C. A. Johnston,et al.  Diverse mitotic functions of the cytoskeletal cross-linking protein Shortstop suggest a role in Dynein/Dynactin activity , 2017, Molecular biology of the cell.

[76]  B. Baradaran,et al.  Balaglitazone reverses P-glycoprotein-mediated multidrug resistance via upregulation of PTEN in a PPARγ-dependent manner in leukemia cells , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[77]  Behzad Baradaran,et al.  The Different Mechanisms of Cancer Drug Resistance: A Brief Review , 2017, Advanced pharmaceutical bulletin.

[78]  L. Chung,et al.  Reactive oxygen species–mediated switching expression of MMP-3 in stromal fibroblasts and cancer cells during prostate cancer progression , 2017, Scientific Reports.

[79]  N. Maishi,et al.  Tumor endothelial cells accelerate tumor metastasis , 2017, Cancer science.

[80]  J. Gamble,et al.  Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell-Mediated Immunotherapy. , 2017, Cancer research.

[81]  M. Zabel,et al.  The Impact of Melatonin on Colon Cancer Cells’ Resistance to Doxorubicin in an In Vitro Study , 2017, International journal of molecular sciences.

[82]  Hongda Wang,et al.  Effects of Tumor Necrosis Factor-α on Morphology and Mechanical Properties of HCT116 Human Colon Cancer Cells Investigated by Atomic Force Microscopy , 2017, Scanning.

[83]  I. Herr,et al.  Melatonin promotes sorafenib‐induced apoptosis through synergistic activation of JNK/c‐jun pathway in human hepatocellular carcinoma , 2017, Journal of pineal research.

[84]  Shun-Fa Yang,et al.  Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis , 2017, International journal of molecular sciences.

[85]  Wenlin Huang,et al.  Melatonin synergizes the chemotherapeutic effect of 5‐fluorouracil in colon cancer by suppressing PI3K/AKT and NF‐κB/iNOS signaling pathways , 2017, Journal of pineal research.

[86]  A. Sala,et al.  Increased dietary levels of α-linoleic acid inhibit mammary tumor growth and metastasis , 2017, European Journal of Nutrition.

[87]  R. Rees,et al.  A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics , 2017, Scientific Reports.

[88]  M. He,et al.  Melatonin attenuates TGFβ1-induced epithelial-mesenchymal transition in lung alveolar epithelial cells. , 2016, Molecular medicine reports.

[89]  Nosratollah Zarghami,et al.  Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge. , 2016, Anti-cancer agents in medicinal chemistry.

[90]  Shun-Fa Yang,et al.  Melatonin suppresses TPA‐induced metastasis by downregulating matrix metalloproteinase‐9 expression through JNK/SP‐1 signaling in nasopharyngeal carcinoma , 2016, Journal of pineal research.

[91]  Weimin Li,et al.  Melatonin induces cell apoptosis in Mia PaCa-2 cells via the suppression of nuclear factor-κB and activation of ERK and JNK: A novel therapeutic implication for pancreatic cancer. , 2016, Oncology reports.

[92]  P. Ghosh,et al.  WOMEN IN CANCER THEMATIC REVIEW: Circadian rhythmicity and the influence of 'clock' genes on prostate cancer. , 2016, Endocrine-related cancer.

[93]  E. Alizadeh,et al.  Downregulation of Notch Signaling Pathway as an Effective Chemosensitizer for Cancer Treatment , 2016, Drug Research.

[94]  R. Ordoñez,et al.  Melatonin‐induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy , 2016, Journal of pineal research.

[95]  M. Rahmati-Yamchi,et al.  Co-inhibition of Notch and NF-κB Signaling Pathway Decreases Proliferation through Downregulating IκB-α and Hes-1 Expression in Human Ovarian Cancer OVCAR-3 Cells , 2016, Drug Research.

[96]  L. D. dos Santos,et al.  Quantitative Proteomic Profiling Reveals That Diverse Metabolic Pathways Are Influenced by Melatonin in an in Vivo Model of Ovarian Carcinoma. , 2016, Journal of proteome research.

[97]  A. Hao,et al.  Melatonin inhibits tumorigenicity of glioblastoma stem‐like cells via the AKT–EZH2–STAT3 signaling axis , 2016, Journal of pineal research.

[98]  Yan Jin,et al.  Melatonin Treatment Improves Mesenchymal Stem Cells Therapy by Preserving Stemness during Long-term In Vitro Expansion , 2016, Theranostics.

[99]  A. Agorastos,et al.  Potential pleiotropic beneficial effects of adjuvant melatonergic treatment in posttraumatic stress disorder , 2016, Journal of pineal research.

[100]  Madhuri S. Kurdi,et al.  The Efficacy of Oral Melatonin in Improving Sleep in Cancer Patients with Insomnia: A Randomized Double-Blind Placebo-Controlled Study , 2016, Indian journal of palliative care.

[101]  L. Ferreira,et al.  Effects of melatonin on HIF-1α and VEGF expression and on the invasive properties of hepatocarcinoma cells. , 2016, Oncology letters.

[102]  R. Rahbarghazi,et al.  Effects of combination of melatonin and laser irradiation on ovarian cancer cells and endothelial lineage viability , 2016, Lasers in Medical Science.

[103]  Hui Liu,et al.  Melatonin downregulates nuclear receptor RZR/RORγ expression causing growth-inhibitory and anti-angiogenesis activity in human gastric cancer cells in vitro and in vivo , 2016, Oncology letters.

[104]  Lu Gao,et al.  CD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis , 2016, Oncotarget.

[105]  A. Hacimuftuoglu,et al.  A Review of Melatonin, Its Receptors and Drugs. , 2016, The Eurasian journal of medicine.

[106]  D. Arnosti,et al.  Melatonin decreases estrogen receptor binding to estrogen response elements sites on the OCT4 gene in human breast cancer stem cells , 2016, Genes & cancer.

[107]  R. Reiter,et al.  Melatonin as a potential anticarcinogen for non-small-cell lung cancer , 2016, Oncotarget.

[108]  Shun-Fa Yang,et al.  Melatonin inhibits MMP‐9 transactivation and renal cell carcinoma metastasis by suppressing Akt‐MAPKs pathway and NF‐κB DNA‐binding activity , 2016, Journal of pineal research.

[109]  R. Reiter,et al.  Melatonin and the von Hippel-Lindau/HIF-1 oxygen sensing mechanism: A review. , 2016, Biochimica et biophysica acta.

[110]  Shun-Fa Yang,et al.  Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation , 2016, Oncotarget.

[111]  Jucimara Colombo,et al.  Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines , 2016, PloS one.

[112]  M. Ben-David,et al.  Melatonin for Prevention of Breast Radiation Dermatitis: A Phase II, Prospective, Double-Blind Randomized Trial. , 2016, The Israel Medical Association journal : IMAJ.

[113]  T. Borin,et al.  Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines. , 2016, Anti-cancer agents in medicinal chemistry.

[114]  E. Akkaya,et al.  A Bifunctional Photosensitizer for Enhanced Fractional Photodynamic Therapy: Singlet Oxygen Generation in the Presence and Absence of Light. , 2016, Angewandte Chemie.

[115]  J. Pariente,et al.  Melatonin sensitizes human cervical cancer HeLa cells to cisplatin‐induced cytotoxicity and apoptosis: effects on oxidative stress and DNA fragmentation , 2016, Journal of pineal research.

[116]  A. Arbab,et al.  Melatonin decreases breast cancer metastasis by modulating Rho‐associated kinase protein‐1 expression , 2016, Journal of pineal research.

[117]  Long Bai,et al.  Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor‐κB activation , 2016, Journal of pineal research.

[118]  B. Baradaran,et al.  Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. , 2015, Cellular and molecular biology.

[119]  Wenlin Huang,et al.  Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells , 2015, Oncotarget.

[120]  Javier González-Gallego,et al.  Melatonin and endoplasmic reticulum stress: relation to autophagy and apoptosis , 2015, Journal of pineal research.

[121]  R. Schreiber,et al.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression , 2015, Cell.

[122]  T. Kizaki,et al.  Melatonin promotes adipogenesis and mitochondrial biogenesis in 3T3‐L1 preadipocytes , 2015, Journal of pineal research.

[123]  X. Chen,et al.  Melatonin reverses H2O2‐induced premature senescence in mesenchymal stem cells via the SIRT1‐dependent pathway , 2015, Journal of pineal research.

[124]  I. Antolín,et al.  Melatonin Cytotoxicity Is Associated to Warburg Effect Inhibition in Ewing Sarcoma Cells , 2015, PloS one.

[125]  Lin Yuan,et al.  Doxorubicin resistance in breast cancer is driven by light at night‐induced disruption of the circadian melatonin signal , 2015, Journal of pineal research.

[126]  A. Calpena,et al.  Evaluating the Oxidative Stress in Inflammation: Role of Melatonin , 2015, International journal of molecular sciences.

[127]  Kevin J. Harrington,et al.  The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence , 2015, Nature Reviews Cancer.

[128]  S. Hill,et al.  Melatonin: an inhibitor of breast cancer. , 2015, Endocrine-related cancer.

[129]  Isabel S Sousa,et al.  Melatonin antiproliferative effects require active mitochondrial function in embryonal carcinoma cells , 2015, Oncotarget.

[130]  Yang Yang,et al.  Melatonin as a treatment for gastrointestinal cancer: a review , 2015, Journal of pineal research.

[131]  S. Woo,et al.  Melatonin‐mediated Bim up‐regulation and cyclooxygenase‐2 (COX‐2) down‐regulation enhances tunicamycin‐induced apoptosis in MDA‐MB‐231 cells , 2015, Journal of pineal research.

[132]  Isaac M. Adjei,et al.  Modulation of the Tumor Microenvironment for Cancer Treatment: A Biomaterials Approach , 2015, Journal of functional biomaterials.

[133]  A. Hao,et al.  Cytoprotective effect of melatonin against hypoxia/serum deprivation-induced cell death of bone marrow mesenchymal stem cells in vitro. , 2015, European journal of pharmacology.

[134]  S. Hill,et al.  The aging clock and circadian control of metabolism and genome stability , 2015, Front. Genet..

[135]  G. Benítez-King,et al.  Melatonin Stimulates Dendrite Formation and Complexity in the Hilar Zone of the Rat Hippocampus: Participation of the Ca++/Calmodulin Complex , 2015, International journal of molecular sciences.

[136]  Yuhuang Li,et al.  MicroRNA-130a associates with ribosomal protein L11 to suppress c-Myc expression in response to UV irradiation , 2014, Oncotarget.

[137]  N. Johns,et al.  Melatonin in patients with cancer receiving chemotherapy: a randomized, double-blind, placebo-controlled trial. , 2014, Anticancer research.

[138]  Y. Song,et al.  Metabolic orchestration between cancer cells and tumor microenvironment as a co-evolutionary source of chemoresistance in ovarian cancer: a therapeutic implication. , 2014, Biochemical pharmacology.

[139]  B. Yousefi,et al.  Anti-arrhythmic effect of diosgenin in reperfusion-induced myocardial injury in a rat model: activation of nitric oxide system and mitochondrial KATP channel , 2014, The Journal of Physiological Sciences.

[140]  Lin Yuan,et al.  Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer. , 2014, Cancer research.

[141]  Sung-Hoon Kim,et al.  Melatonin Sensitizes H1975 Non-Small-Cell Lung Cancer Cells Harboring a T790M-Targeted Epidermal Growth Factor Receptor Mutation to the Tyrosine Kinase Inhibitor Gefitinib , 2014, Cellular Physiology and Biochemistry.

[142]  L. Gu,et al.  Melatonin Suppresses Hypoxia-Induced Migration of HUVECs via Inhibition of ERK/Rac1 Activation , 2014, International journal of molecular sciences.

[143]  Yuan Wang,et al.  Melatonin Inhibits the Migration of Human Lung Adenocarcinoma A549 Cell Lines Involving JNK/MAPK Pathway , 2014, PloS one.

[144]  Ju-Hee Lee,et al.  Overcoming Hypoxic-Resistance of Tumor Cells to TRAIL-Induced Apoptosis through Melatonin , 2014, International journal of molecular sciences.

[145]  C. Alonso-González,et al.  Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review) , 2014, Oncology letters.

[146]  R. Reiter,et al.  Melatonin regulates mesenchymal stem cell differentiation: a review , 2014, Journal of pineal research.

[147]  J. Rosenberg,et al.  Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial , 2014, Breast Cancer Research and Treatment.

[148]  A. Giobbie-Hurder,et al.  A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes , 2014, Breast Cancer Research and Treatment.

[149]  D. Cardinali,et al.  Melatonin Therapy in Patients with Alzheimer’s Disease , 2014, Antioxidants.

[150]  M. Ohmura,et al.  Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway , 2014, Nature Communications.

[151]  S. Gordon,et al.  The M1 and M2 paradigm of macrophage activation: time for reassessment , 2014, F1000prime reports.

[152]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[153]  R. Reiter,et al.  Extrapineal melatonin: sources, regulation, and potential functions , 2014, Cellular and Molecular Life Sciences.

[154]  A. Cutando,et al.  Action of melatonin on squamous cell carcinoma and other tumors of the oral cavity (Review) , 2014, Oncology letters.

[155]  Ali S. Arbab,et al.  Effect of Melatonin on Tumor Growth and Angiogenesis in Xenograft Model of Breast Cancer , 2014, PloS one.

[156]  R. Ordoñez,et al.  Inhibition of matrix metalloproteinase‐9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells , 2014, Journal of pineal research.

[157]  M. Bizzarri,et al.  Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review , 2013, Expert opinion on therapeutic targets.

[158]  A. Hao,et al.  Melatonin antagonizes hypoxia‐mediated glioblastoma cell migration and invasion via inhibition of HIF‐1α , 2013, Journal of pineal research.

[159]  Wei Wei,et al.  Melatonin reverses tunicamycin‐induced endoplasmic reticulum stress in human hepatocellular carcinoma cells and improves cytotoxic response to doxorubicin by increasing CHOP and decreasing Survivin , 2013, Journal of pineal research.

[160]  Wei Wei,et al.  Melatonin overcomes apoptosis resistance in human hepatocellular carcinoma by targeting Survivin and XIAP , 2013, Journal of pineal research.

[161]  M. Bizzarri,et al.  Molecular mechanisms of melatonin’s inhibitory actions on breast cancers , 2013, Cellular and Molecular Life Sciences.

[162]  R. Kontek,et al.  The modulatory effect of melatonin on genotoxicity of irinotecan in healthy human lymphocytes and cancer cells , 2013, Drug and chemical toxicology.

[163]  C. Alonso-González,et al.  Melatonin modulates aromatase activity and expression in endothelial cells. , 2013, Oncology reports.

[164]  A. Rodríguez-Rodríguez,et al.  Melatonin: Buffering the Immune System , 2013, International journal of molecular sciences.

[165]  D. Cardinali,et al.  Melatonin Antioxidative Defense: Therapeutical Implications for Aging and Neurodegenerative Processes , 2013, Neurotoxicity Research.

[166]  J. Mayo,et al.  Phenotypic changes caused by melatonin increased sensitivity of prostate cancer cells to cytokine‐induced apoptosis , 2013, Journal of pineal research.

[167]  T. Hagemann,et al.  The tumor microenvironment at a glance , 2012, Journal of Cell Science.

[168]  Sung-Hoon Kim,et al.  Inhibition of Connexin 26/43 and Extracellular-Regulated Kinase Protein Plays a Critical Role in Melatonin Facilitated Gap Junctional Intercellular Communication in Hydrogen Peroxide-Treated HaCaT Keratinocyte Cells , 2012, Evidence-based complementary and alternative medicine : eCAM.

[169]  S. Hill,et al.  Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3β. , 2012, Molecular endocrinology.

[170]  A. C. Uguz,et al.  Melatonin potentiates chemotherapy‐induced cytotoxicity and apoptosis in rat pancreatic tumor cells , 2012, Journal of pineal research.

[171]  Wenlin Huang,et al.  Simultaneous modulation of COX‐2, p300, Akt, and Apaf‐1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells , 2012, Journal of pineal research.

[172]  R. Reiter,et al.  Gene regulation by melatonin linked to epigenetic phenomena. , 2012, Gene.

[173]  C. Alonso-González,et al.  Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production , 2012, Journal of pineal research.

[174]  Wei Wei,et al.  Melatonin sensitizes human hepatoma cells to endoplasmic reticulum stress–induced apoptosis , 2012, Journal of pineal research.

[175]  Sean J Morrison,et al.  Cancer stem cells: impact, heterogeneity, and uncertainty. , 2012, Cancer cell.

[176]  Soo-Jin Jeong,et al.  Melatonin synergistically enhances cisplatin‐induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK‐OV‐3 cells , 2012, Journal of pineal research.

[177]  R. Reiter,et al.  Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations , 2012, Journal of pineal research.

[178]  A. Giobbie-Hurder,et al.  A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers , 2012, Cancer Causes & Control.

[179]  H. Sasano,et al.  Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts , 2012, Breast Cancer Research and Treatment.

[180]  A. Aboussekhra.  Role of cancer-associated fibroblasts in breast cancer development and prognosis. , 2011, The International journal of developmental biology.

[181]  I. Shureiqi,et al.  15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in? , 2011, Cancer and Metastasis Reviews.

[182]  T. Hasan,et al.  Mechanisms of resistance to photodynamic therapy. , 2011, Current medicinal chemistry.

[183]  Soo-Jin Jeong,et al.  Melatonin promotes puromycin‐induced apoptosis with activation of caspase‐3 and 5′‐adenosine monophosphate‐activated kinase‐alpha in human leukemia HL‐60 cells , 2011, Journal of pineal research.

[184]  D. Cardinali,et al.  Melatonin—A pleiotropic, orchestrating regulator molecule , 2011, Progress in Neurobiology.

[185]  S. Hill,et al.  Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway , 2010, Breast Cancer Research.

[186]  L. Ghibelli,et al.  Melatonin: a pleiotropic molecule regulating inflammation. , 2010, Biochemical pharmacology.

[187]  K. Kaibuchi,et al.  Rho-Kinase/ROCK: A Key Regulator of the Cytoskeleton and Cell Polarity , 2010, Cytoskeleton.

[188]  A. Harris,et al.  Mechanisms of resistance to antiangiogenesis therapy. , 2010, European journal of cancer.

[189]  Wei Wei,et al.  Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines. , 2010, World journal of gastroenterology.

[190]  N. Ferrara.  Pathways mediating VEGF-independent tumor angiogenesis. , 2010, Cytokine & growth factor reviews.

[191]  G. García‐Santos,et al.  Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death. , 2010, Cancer letters.

[192]  Tripp Frasch,et al.  Molecular Mechanisms of Melatonin Anticancer Effects , 2009, Integrative cancer therapies.

[193]  S. Joo,et al.  Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer , 2009, Journal of pineal research.

[194]  R. Reiter,et al.  Role of melatonin in the epigenetic regulation of breast cancer , 2009, Breast Cancer Research and Treatment.

[195]  G. Benítez-King,et al.  ROCK‐regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration , 2009, Journal of pineal research.

[196]  M. Mehta,et al.  Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119). , 2007, International journal of radiation oncology, biology, physics.

[197]  N. Ahmad,et al.  Melatonin in cancer management: progress and promise. , 2006, Cancer research.

[198]  C. Martínez-Campa,et al.  Melatonin modulates aromatase activity in MCF‐7 human breast cancer cells , 2005, Journal of pineal research.

[199]  E. Crivellato,et al.  Involvement of mast cells in angiogenesis and chronic inflammation. , 2005, Current drug targets. Inflammation and allergy.

[200]  R. Reiter,et al.  Mechanisms of cancer inhibition by melatonin , 2004, Journal of pineal research.

[201]  D. Blask,et al.  Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin. , 2004, Carcinogenesis.

[202]  Josep M. Guerrero,et al.  Melatonin inhibits telomerase activity in the MCF‐7 tumor cell line both in vivo and in vitro , 2003, Journal of pineal research.

[203]  P. Lissoni,et al.  Five years survival in metastatic non‐small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial , 2003, Journal of pineal research.

[204]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[205]  S. Bulun,et al.  Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue. , 2002, Molecular endocrinology.

[206]  R. Reiter,et al.  Melatonin: reducing the toxicity and increasing the efficacy of drugs , 2002, The Journal of pharmacy and pharmacology.

[207]  G. Decorti,et al.  Effects of melatonin on doxorubicin cytotoxicity in sensitive and pleiotropically resistant tumor cells , 2001, Journal of pineal research.

[208]  S. Bulun,et al.  Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta. , 2001, Cancer research.

[209]  R. Reiter,et al.  Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation. , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[210]  D. Blask,et al.  13-Hydroxyoctadecadienoic acid is the mitogenic signal for linoleic acid-dependent growth in rat hepatoma 7288CTC in vivo. , 1999, Cancer research.

[211]  D. Blask,et al.  Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. , 1999, Cancer research.

[212]  G. Gabbiani,et al.  Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction , 1971, Experientia.

[213]  P. Chiarugi,et al.  Tumors and their microenvironment , 2021 .

[214]  Puneet Kumar,et al.  Pharmacology of Melatonin and Its Receptors , 2020 .

[215]  A. Theocharis,et al.  Strategies to Target Matrix Metalloproteinases as Therapeutic Approach in Cancer. , 2018, Methods in molecular biology.

[216]  Quentin Liu,et al.  Targeting NF-κB/AP-2β signaling to enhance antitumor activity of cisplatin by melatonin in hepatocellular carcinoma cells. , 2017, American journal of cancer research.

[217]  Mohammad Esmaeil Akbari,et al.  Melatonin, an inhibitory agent in breast cancer , 2016, Breast Cancer.

[218]  Y. Wang,et al.  Melatonin inhibits the Migration of Colon Cancer RKO cells by Down-regulating Myosin Light Chain Kinase Expression through Cross-talk with p38 MAPK. , 2015, Asian Pacific Journal of Cancer Prevention.

[219]  J. Saluk,et al.  Melatonin redox activity. Its potential clinical applications in neurodegenerative disorders. , 2015, Current topics in medicinal chemistry.

[220]  S. Cuzzocrea,et al.  Role of melatonin supplementation in neurodegenerative disorders. , 2014, Frontiers in bioscience.

[221]  G. D. Bella,et al.  Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: a preliminary report. , 2013, Neuro endocrinology letters.

[222]  You-qing Xu,et al.  Melatonin inhibits the expression of vascular endothelial growth factor in pancreatic cancer cells , 2012 .

[223]  R. Gillies,et al.  Targeting the metabolic microenvironment of tumors. , 2012, Advances in pharmacology.

[224]  C. Alonso-González,et al.  Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions. , 2006, Cancer detection and prevention.

[225]  R. Reiter,et al.  Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. , 2003, Acta biochimica Polonica.

[226]  R. Reiter,et al.  Endocrine aspects of the mammalian pineal gland: a review. , 1969, Neuroendocrinology.